Enokida, Yuki

Fujii, Akiko

Hara, Kentaro

Ikeda, Tokunori

Morinaga, Jun

Nakahara, Keiichi

Narita, Sawana

Takamatsu, Koutaro

Tanoue, Naomi

Tawara, Nozomu

Yamanouchi, Yoshinori

Yamashita, Satoshi

Muscle biopsy can be used to confirm the diagnosis of neuromuscular diseases. However, it is unclear whether antibiotic prophylaxis prior to muscle biopsy is needed to prevent surgical site infection (SSI). We are conducting a phase 2, single-center, open-labeled, prospective randomized trial to clarify the need for antibiotic prophylaxis in patients at low risk for SSI undergoing muscle biopsy. Patients will be randomized to an antibiotic prophylaxis group or a control group, and the incidence of SSI will be compared between the groups. Our findings will clarify the need for antibiotic prophylaxis in this patient population

Institutional Repositories DataBase (IRDB)

A Randomized Phase 2 Trial of Antibiotic Prophylaxis Versus No Intervention for Muscle Biopsy in A Neurology Department

A Randomized Phase 2 Trial of Antibiotic Prophylaxis Versus No Intervention for Muscle Biopsy in A Neurology Department

Abstract

Similar works

Full text

Available Versions

Institutional Repositories DataBase (IRDB)